A detailed history of Transcend Capital Advisors, LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 16,500 shares of RXST stock, worth $555,390. This represents 0.06% of its overall portfolio holdings.

Number of Shares
16,500
Previous 16,835 1.99%
Holding current value
$555,390
Previous $1.01 Million 19.47%
% of portfolio
0.06%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$40.78 - $57.04 $13,661 - $19,108
-335 Reduced 1.99%
16,500 $815,000
Q2 2024

Jul 02, 2024

SELL
$50.42 - $64.29 $14,369 - $18,322
-285 Reduced 1.66%
16,835 $1.01 Million
Q1 2024

May 03, 2024

BUY
$35.51 - $57.92 $22,016 - $35,910
620 Added 3.76%
17,120 $883,000
Q2 2023

Jul 13, 2023

BUY
$16.37 - $28.9 $270,105 - $476,850
16,500 New
16,500 $475,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $930M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Transcend Capital Advisors, LLC Portfolio

Follow Transcend Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.